Selected research
Industry Growth & Trends
Global Nuclear Medicine Software Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Nuclear Medicine Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Nuclear Medicine Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Nuclear Medicine Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Nuclear Medicine Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Nuclear Medicine Software market include iQ IMAGE, Mediso, Segami, Hermes Medical Solutions, MIM Software Inc, LabLogic, scintido, Gamma Gurus and Mirion Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Nuclear Medicine Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Nuclear Medicine Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nuclear Medicine Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nuclear Medicine Software.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Nuclear Medicine Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Nuclear Medicine Software Market by Company
iQ IMAGE
Mediso
Segami
Hermes Medical Solutions
MIM Software Inc
LabLogic
scintido
Gamma Gurus
Mirion Medical
PAIRE
GE HealthCare
Inter Medical
Sirona
Nuclear Medicine Software Segment by Type
Drug Management
Radiation Management
Other
Nuclear Medicine Software Segment by Application
Clinical Diagnosis
Research
Others
Nuclear Medicine Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Nuclear Medicine Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Drug Management
- Radiation Management
- Other
Applications
- Clinical Diagnosis
- Research
- Others
Companies covered
- iQ IMAGE
- Mediso
- Segami
- Hermes Medical Solutions
- MIM Software Inc
- LabLogic
- scintido
- Gamma Gurus
- Mirion Medical
- PAIRE
- GE HealthCare
- Inter Medical
- Sirona
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Nuclear Medicine Software Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Nuclear Medicine Software Market Size by Region (2021-2032)
- 1.4.1 Global Nuclear Medicine Software Market Size by Region (2021-2026)
- 1.4.2 Global Nuclear Medicine Software Market Size by Region (2027-2032)
- 1.5 Key Regions Nuclear Medicine Software Market Size (2021-2032)
- 1.5.1 North America Nuclear Medicine Software Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Nuclear Medicine Software Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Nuclear Medicine Software Market Size Growth Rate (2021-2032)
- 1.5.4 South America Nuclear Medicine Software Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Nuclear Medicine Software Market Size Growth Rate (2021-2032)
2 Nuclear Medicine Software Market by Type
- 2.1 Type Introduction
- 2.1.1 Drug Management
- 2.1.2 Radiation Management
- 2.1.3 Other
- 2.2 Global Nuclear Medicine Software Market Size by Type
- 2.2.1 Global Nuclear Medicine Software Market Size Overview by Type (2021-2032)
- 2.2.2 Global Nuclear Medicine Software Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Nuclear Medicine Software Market Size Forecasted by Type (2027-2032)
- 2.3 Global Nuclear Medicine Software Market Size by Regions
- 2.3.1 North America Nuclear Medicine Software Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Nuclear Medicine Software Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Nuclear Medicine Software Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Nuclear Medicine Software Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Nuclear Medicine Software Market Size Breakdown by Type (2021-2026)
3 Nuclear Medicine Software Market by Application
- 3.1 Type Introduction
- 3.1.1 Clinical Diagnosis
- 3.1.2 Research
- 3.1.3 Others
- 3.2 Global Nuclear Medicine Software Market Size by Application
- 3.2.1 Global Nuclear Medicine Software Market Size Overview by Application (2021-2032)
- 3.2.2 Global Nuclear Medicine Software Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Nuclear Medicine Software Market Size Forecasted by Application (2027-2032)
- 3.3 Global Nuclear Medicine Software Market Size by Regions
- 3.3.1 North America Nuclear Medicine Software Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Nuclear Medicine Software Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Nuclear Medicine Software Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Nuclear Medicine Software Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Nuclear Medicine Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Nuclear Medicine Software Industry Trends
- 4.2 Nuclear Medicine Software Industry Drivers
- 4.3 Nuclear Medicine Software Industry Opportunities and Challenges
- 4.4 Nuclear Medicine Software Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Nuclear Medicine Software Revenue (2021-2026)
- 5.2 Global Nuclear Medicine Software Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Nuclear Medicine Software Key Company Headquarters & Area Served
- 5.4 Global Nuclear Medicine Software Company, Product Type & Application
- 5.5 Global Nuclear Medicine Software Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Nuclear Medicine Software Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Nuclear Medicine Software Players Market Share by Revenue in 2025
- 5.6.3 2025 Nuclear Medicine Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 iQ IMAGE
- 6.1.1 iQ IMAGE Company Information
- 6.1.2 iQ IMAGE Business Overview
- 6.1.3 iQ IMAGE Nuclear Medicine Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 iQ IMAGE Nuclear Medicine Software Product Portfolio
- 6.1.5 iQ IMAGE Recent Developments
- 6.2 Mediso
- 6.2.1 Mediso Company Information
- 6.2.2 Mediso Business Overview
- 6.2.3 Mediso Nuclear Medicine Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Mediso Nuclear Medicine Software Product Portfolio
- 6.2.5 Mediso Recent Developments
- 6.3 Segami
- 6.3.1 Segami Company Information
- 6.3.2 Segami Business Overview
- 6.3.3 Segami Nuclear Medicine Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Segami Nuclear Medicine Software Product Portfolio
- 6.3.5 Segami Recent Developments
- 6.4 Hermes Medical Solutions
- 6.4.1 Hermes Medical Solutions Company Information
- 6.4.2 Hermes Medical Solutions Business Overview
- 6.4.3 Hermes Medical Solutions Nuclear Medicine Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Hermes Medical Solutions Nuclear Medicine Software Product Portfolio
- 6.4.5 Hermes Medical Solutions Recent Developments
- 6.5 MIM Software Inc
- 6.5.1 MIM Software Inc Company Information
- 6.5.2 MIM Software Inc Business Overview
- 6.5.3 MIM Software Inc Nuclear Medicine Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 MIM Software Inc Nuclear Medicine Software Product Portfolio
- 6.5.5 MIM Software Inc Recent Developments
- 6.6 LabLogic
- 6.6.1 LabLogic Company Information
- 6.6.2 LabLogic Business Overview
- 6.6.3 LabLogic Nuclear Medicine Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 LabLogic Nuclear Medicine Software Product Portfolio
- 6.6.5 LabLogic Recent Developments
- 6.7 scintido
- 6.7.1 scintido Company Information
- 6.7.2 scintido Business Overview
- 6.7.3 scintido Nuclear Medicine Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 scintido Nuclear Medicine Software Product Portfolio
- 6.7.5 scintido Recent Developments
- 6.8 Gamma Gurus
- 6.8.1 Gamma Gurus Company Information
- 6.8.2 Gamma Gurus Business Overview
- 6.8.3 Gamma Gurus Nuclear Medicine Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Gamma Gurus Nuclear Medicine Software Product Portfolio
- 6.8.5 Gamma Gurus Recent Developments
- 6.9 Mirion Medical
- 6.9.1 Mirion Medical Company Information
- 6.9.2 Mirion Medical Business Overview
- 6.9.3 Mirion Medical Nuclear Medicine Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Mirion Medical Nuclear Medicine Software Product Portfolio
- 6.9.5 Mirion Medical Recent Developments
- 6.10 PAIRE
- 6.10.1 PAIRE Company Information
- 6.10.2 PAIRE Business Overview
- 6.10.3 PAIRE Nuclear Medicine Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 PAIRE Nuclear Medicine Software Product Portfolio
- 6.10.5 PAIRE Recent Developments
- 6.11 GE HealthCare
- 6.11.1 GE HealthCare Company Information
- 6.11.2 GE HealthCare Business Overview
- 6.11.3 GE HealthCare Nuclear Medicine Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 GE HealthCare Nuclear Medicine Software Product Portfolio
- 6.11.5 GE HealthCare Recent Developments
- 6.12 Inter Medical
- 6.12.1 Inter Medical Company Information
- 6.12.2 Inter Medical Business Overview
- 6.12.3 Inter Medical Nuclear Medicine Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Inter Medical Nuclear Medicine Software Product Portfolio
- 6.12.5 Inter Medical Recent Developments
- 6.13 Sirona
- 6.13.1 Sirona Company Information
- 6.13.2 Sirona Business Overview
- 6.13.3 Sirona Nuclear Medicine Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Sirona Nuclear Medicine Software Product Portfolio
- 6.13.5 Sirona Recent Developments
7 North America
- 7.1 North America Nuclear Medicine Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Nuclear Medicine Software Market Size by Country (2021-2026)
- 7.3 North America Nuclear Medicine Software Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Nuclear Medicine Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Nuclear Medicine Software Market Size by Country (2021-2026)
- 8.3 Europe Nuclear Medicine Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Nuclear Medicine Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Nuclear Medicine Software Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Nuclear Medicine Software Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Nuclear Medicine Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Nuclear Medicine Software Market Size by Country (2021-2026)
- 10.3 South America Nuclear Medicine Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Nuclear Medicine Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Nuclear Medicine Software Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Nuclear Medicine Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst